New meningitis booster shows promise in phase 3 trial
NCT ID NCT04084769
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a booster dose of an experimental meningitis vaccine (MenACYW) in 570 healthy teens and adults who had received a meningitis vaccine 3-6 years earlier. The goal was to see if the booster could restore strong immunity against four types of meningococcal bacteria. Results will help determine if this vaccine can be used as a booster to maintain protection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine (MenACYW)
What this could lead to
If successful, this could provide a safe and effective booster option to maintain protection against meningococcal disease in adolescents and adults.
What could go wrong
This is a completed Phase 3 trial, so results are already in. However, the vaccine is still investigational and may not be approved or widely available. Side effects are possible, as with any vaccine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL IMMUNISATION (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 6300001
San Juan, 00981, Puerto Rico
-
Investigational Site Number 8400001
Layton, Utah, 84041, United States
-
Investigational Site Number 8400002
Lincoln, Nebraska, 68505, United States
-
Investigational Site Number 8400003
Salt Lake City, Utah, 84107, United States
-
Investigational Site Number 8400004
Lincoln, Nebraska, 68516, United States
-
Investigational Site Number 8400005
San Diego, California, 92123-1881, United States
-
Investigational Site Number 8400007
Salt Lake City, Utah, 84109, United States
-
Investigational Site Number 8400009
Norman, Oklahoma, 73069, United States
-
Investigational Site Number 8400011
Provo, Utah, 84064, United States
-
Investigational Site Number 8400012
Birmingham, Alabama, 35205, United States
-
Investigational Site Number 8400013
Bardstown, Kentucky, 40004, United States
-
Investigational Site Number 8400014
Layton, Utah, 84041, United States
-
Investigational Site Number 8400015
South Jordan, Utah, 84095, United States
-
Investigational Site Number 8400018
Kingsport, Tennessee, 37660, United States
-
Investigational Site Number 8400022
Salt Lake City, Utah, 84109, United States
-
Investigational Site Number 8400023
Roy, Utah, 84067, United States
-
Investigational Site Number 8400024
West Jordan, Utah, 84088-8865, United States
-
Investigational Site Number 8400027
Lincoln, Nebraska, 68504, United States
-
Investigational Site Number 8400028
South Euclid, Ohio, 44121, United States
-
Investigational Site Number 8400029
Tullahoma, Tennessee, 37388, United States
-
Investigational Site Number 8400030
Dayton, Ohio, 45414, United States
-
Investigational Site Number 8400031
Kaysville, Utah, 84037, United States
-
Investigational Site Number 8400032
Syracuse, Utah, 84075-9645, United States
-
Investigational Site Number 8400033
Lexington, Kentucky, 40517, United States
-
Investigational Site Number 8400034
Bridgeton, Missouri, 63044, United States
-
Investigational Site Number 8400036
South Jordan, Utah, 84095, United States
-
Investigational Site Number 8400037
Charlottesville, Virginia, 22903, United States
-
Investigational Site Number 8400038
Erie, Pennsylvania, 16505, United States
-
Investigational Site Number 8400039
Charleston, South Carolina, 29414, United States
-
Investigational Site Number 8400040
Orem, Utah, 84057, United States